Satellos Bioscience Inc.MSLE

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$8.71
Market cap
$184.8M
P/E
—
Revenue (FY)
—
Net income
-$24.9M
Dividend yield
—
1-year total return
50.3%
Net margin
—
Revenue growth
—
Debt / equity
—

What Satellos Bioscience Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202320242025
Net income—-$20.6M-$24.9M
Free cash flow—-$18.3M-$23.6M

More on MSLE.

Figures from Satellos Bioscience Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.